Preclinical Efficacy and Mechanisms of Mesenchymal Stem Cells in Animal Models of Autoimmune Diseases |
Lee, Hong Kyung
(College of Pharmacy, Chungbuk National University)
Lim, Sang Hee (College of Pharmacy, Chungbuk National University) Chung, In Sung (College of Pharmacy, Chungbuk National University) Park, Yunsoo (College of Pharmacy, Chungbuk National University) Park, Mi Jeong (College of Pharmacy, Chungbuk National University) Kim, Ju Young (College of Pharmacy, Chungbuk National University) Kim, Yong Guk (College of Pharmacy, Chungbuk National University) Hong, Jin Tae (College of Pharmacy, Chungbuk National University) Kim, Youngsoo (College of Pharmacy, Chungbuk National University) Han, Sang-Bae (College of Pharmacy, Chungbuk National University) |
1 | Zhang, W., W. Ge, C. Li, S. You, L. Liao, Q. Han, W. Deng, and R. C. Zhao. 2004. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte- derived dendritic cells. Stem Cells Dev. 13: 263-271. DOI ScienceOn |
2 | Augello, A., R. Tasso, S. M. Negrini, R. Cancedda, and G. Pennesi. 2007. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen- induced arthritis. Arthritis Rheum. 56: 1175-1186. DOI ScienceOn |
3 | Papadopoulou, A., M. Yiangou, E. Athanasiou, N. Zogas, P. Kaloyannidis, I. Batsis, A. Fassas, A. Anagnostopoulos, and E. Yannaki. 2012. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann. Rheum. Dis. 71: 1733-1740. DOI |
4 | Gonzalez, M. A., E. Gonzalez-Rey, L. Rico, D. Buscher, and M. Delgado. 2009. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136: 978-989. DOI ScienceOn |
5 | Bouma, G. and W. Strober. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533. DOI ScienceOn |
6 | Akiyama, K., C. Chen, D. Wang, X. Xu, C. Qu, T. Yamaza, T. Cai, W. Chen, L. Sun, and S. Shi. 2012. Mesenchymalstem- cell-induced immunoregulation involves FAS-ligand-/ FAS-mediated T cell apoptosis. Cell Stem Cell 10: 544-555. DOI ScienceOn |
7 | Zappia, E., S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, E. Gerdoni, D. Giunti, A. Ceravolo, F. Cazzanti, F. Frassoni, G. Mancardi, and A. Uccelli. 2005. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761. DOI ScienceOn |
8 | Gerdoni, E., B. Gallo, S. Casazza, S. Musio, I. Bonanni, E. Pedemonte, R. Mantegazza, F. Frassoni, G. Mancardi, R. Pedotti, and A. Uccelli. 2007. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61: 219-227. DOI ScienceOn |
9 | Nauta, A. J., A. B. Kruisselbrink, E. Lurvink, R. Willemze, and W. E. Fibbe. 2006. Mesenchymal stem cells inhibit generation and function of both -derived and monocyte- derived dendritic cells. J. Immunol. 177: 2080-2087. DOI |
10 | Ji, S., Q. Guo, Y. Han, G. Tan, Y. Luo, and F. Zeng. 2012. Mesenchymal stem cell transplantation inhibits abnormal activation of Akt/GSK3beta signaling pathway in T cells from systemic lupus erythematosus mice. Cell Physiol. Biochem. 29: 705-712. DOI ScienceOn |
11 | Zhou, K., H. Zhang, O. Jin, X. Feng, G. Yao, Y. Hou, and L. Sun. 2008. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol. Immunoly. 5: 417-424. DOI |
12 | Youd, M., C. Blickarz, L. Woodworth, T. Touzjian, A. Edling, J. Tedstone, M. Ruzek, R. Tubo, J. Kaplan, and T. Lodie. 2010. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin. Exp. Immunol. 161: 176-186. |
13 | Schena, F., C. Gambini, A. Gregorio, M. Mosconi, D. Reverberi, M. Gattorno, S. Casazza, A. Uccelli, L. Moretta, A. Martini, and E. Traggiai. 2010. Interferon-gamma-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum. 62: 2776-2786. DOI ScienceOn |
14 | Choi, E. W., I. S. Shin, S. Y. Park, J. H. Park, J. S. Kim, E. J. Yoon, S. K. Kang, J. C. Ra, and S. H. Hong. 2012. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum. 64: 243-253. DOI ScienceOn |
15 | Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361. DOI ScienceOn |
16 | Liu, Y., R. Mu, S. Wang, L. Long, X. Liu, R. Li, J. Sun, J. Guo, X. Zhang, J. Guo, P. Yu, C. Li, X. Liu, Z. Huang, D. Wang, H. Li, Z. Gu, B. Liu, and Z. Li. 2010. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res. Ther. 12: R210. DOI ScienceOn |
17 | Zhou, B., J. Yuan, Y. Zhou, M. Ghawji, Jr., Y. P. Deng, A. J. Lee, A. J. Lee, U. Nair, A. H. Kang, D. D. Brand, and T. J. Yoo. 2011. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis. Clin. Immunol. 141: 328-337. DOI ScienceOn |
18 | Duijvestein, M., A. C. Vos, H. Roelofs, M. E. Wildenberg, B. B. Wendrich, H. W. Verspaget, E. M. Kooy-Winkelaar, F. Koning, J. J. Zwaginga, H. H. Fidder, A. P. Verhaar, W. E. Fibbe, G. R. van den Brink, and D. W. Hommes. 2010. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 59: 1662-1669. DOI ScienceOn |
19 | Ball, L. M., M. E. Bernardo, H. Roelofs, A. Lankester, A. Cometa, R. M. Egeler, F. Locatelli, and W. E. Fibbe. 2007. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110: 2764-2767. DOI ScienceOn |
20 | Le Blanc, K., F. Frassoni, L. Ball, F. Locatelli, H. Roelofs, I. Lewis, E. Lanino, B. Sundberg, M. E. Bernardo, M. Remberger, G. Dini, R. M. Egeler, A. Bacigalupo, W. Fibbe, O. Ringden ; Developmental Committee of the European Group for Blood and Marrow Transplantation. 2008. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371: 1579-1586. DOI ScienceOn |
21 | Le Blanc, K., I. Rasmusson, B. Sundberg, C. Gotherstrom, M. Hassan, M. Uzunel, and O. Ringden. 2004. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441. DOI ScienceOn |
22 | Gu, Z., K. Akiyama, X. Ma, H. Zhang, X. Feng, G. Yao, Y. Hou, L. Lu, G. S. Gilkeson, R. M. Silver, X. Zeng, S. Shi, and L. Sun. 2010. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 19: 1502-1514. DOI ScienceOn |
23 | Solchaga, L. A., J. S. Temenoff, J. Gao, A. G. Mikos, A. I. Caplan, and V. M. Goldberg. 2005. Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthritis Cartilage 13: 297-309. DOI ScienceOn |
24 | Horwitz, E. M., K. Le Blanc, M. Dominici, I. Mueller, I. Slaper-Cortenbach, F. C. Marini, R. J. Deans, D. S. Krause, A. Keating ; International Society for Cellular Therapy. 2005. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395. DOI ScienceOn |
25 | Miyahara, Y., N. Nagaya, M. Kataoka, B. Yanagawa, K. Tanaka, H. Hao, K. Ishino, H. Ishida, T. Shimizu, K. Kangawa, S. Sano, T. Okano, S. Kitamura, and H. Mori. 2006. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12: 459-465. DOI ScienceOn |
26 | Dominici, M., K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, and E. Horwitz. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317. DOI ScienceOn |
27 | Amado, L. C., A. P. Saliaris, K. H. Schuleri, M. St John, J. S. Xie, S. Cattaneo, D. J. Durand, T. Fitton, J. Q. Kuang, G. Stewart, S. Lehrke, W. W. Baumgartner, B. J. Martin, A. W. Heldman, and J. M. Hare. 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 102: 11474-11479. DOI ScienceOn |
28 | Lin, Y. T., Y. Chern, C. K. Shen, H. L. Wen, Y. C. Chang, H. Li, T. H. Cheng, and H. M. Hsieh-Li. 2011. Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models. PLoS One 6: e22924. DOI |
29 | Watt, F. M. and B. L. Hogan. 2000. Out of Eden: stem cells and their niches. Science 287: 1427-1430. DOI ScienceOn |
30 | Thomson, J. A., J. Itskovitz-Eldor, S. S. Shapiro, M. A. Waknitz, J. J. Swiergiel, V. S. Marshall, and J. M. Jones. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147. DOI ScienceOn |
31 | Friedenstein, A. J., R. K. Chailakhjan, and K. S. Lalykina. 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3: 393-403. |
32 | Nussbaum, J., E. Minami, M. A. Laflamme, J. A. Virag, C. B. Ware, A. Masino, V. Muskheli, L. Pabon, H. Reinecke, and C. E. Murry. 2007. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB. J. 21: 1345-1357. DOI ScienceOn |
33 | Ren, G., X. Zhao, L. Zhang, J. Zhang, A. L'Huillier, W. Ling, A. I. Roberts, A. D. Le, S. Shi, C. Shao, and Y. Shi. 2010. Inflammatory cytokine-induced intercellular adhesion molecule- 1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J. Immunol. 184: 2321-2328. DOI ScienceOn |
34 | Kon, E., A. Muraglia, A. Corsi, P. Bianco, M. Marcacci, I. Martin, A. Boyde, I. Ruspantini, P. Chistolini, M. Rocca, R. Giardino, R. Cancedda, and R. Quarto. 2000. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J. Biomed. Mater. Res. 49: 328-337. DOI ScienceOn |
35 | Locatelli, F., R. Maccario, and F. Frassoni. 2007. Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders? Haematologica 92: 872-877. DOI ScienceOn |
36 | Krampera, M., L. Cosmi, R. Angeli, A. Pasini, F. Liotta, A. Andreini, V. Santarlasci, B. Mazzinghi, G. Pizzolo, F. Vinante, P. Romagnani, E. Maggi, S. Romagnani, and F. Annunziato. 2006. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24: 386-398. DOI ScienceOn |
37 | Corcione, A., F. Benvenuto, E. Ferretti, D. Giunti, V. Cappiello, F. Cazzanti, M. Risso, F. Gualandi, G. L. Mancardi, V. Pistoia, and A. Uccelli. 2006. Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372. DOI ScienceOn |
38 | Tabera, S., J. A. Perez-Simon, M. Diez-Campelo, L. I. Sanchez- Abarca, B. Blanco, A. Lopez, A. Benito, E. Ocio, F. M. Sanchez-Guijo, C. Canizo, and J. F. San Miguel. 2008. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93: 1301-1309. DOI ScienceOn |
39 | Chiesa, S., S. Morbelli, S. Morando, M. Massollo, C. Marini, A. Bertoni, F. Frassoni, S. T. Bartolome, G. Sambuceti, E. Traggiai, and A. Uccelli. 2011. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc. Natl. Acad. Sci. USA 108: 17384-17389. DOI ScienceOn |
40 | Spaggiari, G. M., H. Abdelrazik, F. Becchetti, and L. Moretta. 2009. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113: 6576-6583. DOI ScienceOn |
41 | Wehner, R., D. Wehrum, M. Bornhauser, S. Zhao, K. Schakel, M. P. Bachmann, U. Platzbecker, G. Ehninger, E. P. Rieber, and M. Schmitz. 2009. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells. Haematologica 94: 1151-1156. DOI ScienceOn |
42 | Bartholomew, A., C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. Devine, D. Ucker, R. Deans, A. Moseley, and R. Hoffman. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30: 42-48. DOI ScienceOn |
43 | Krampera, M., S. Glennie, J. Dyson, D. Scott, R. Laylor, E. Simpson, and F. Dazzi. 2003. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen- specific T cells to their cognate peptide. Blood 101: 3722-3729. DOI ScienceOn |
44 | Maitra, B., E. Szekely, K. Gjini, M. J. Laughlin, J. Dennis, S. E. Haynesworth, and O. N. Koc. 2004. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33: 597-604. DOI ScienceOn |
45 | Gonzalez-Rey, E., M. A. Gonzalez, N. Varela, F. O'Valle, P. Hernandez-Cortes, L. Rico, D. Buscher, and M. Delgado. 2010. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann. Rheum. Dis. 69: 241-248. DOI ScienceOn |
46 | Aggarwal, S. and M. F. Pittenger. 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. DOI ScienceOn |
47 | Jiang, X. X., Y. Zhang, B. Liu, S. X. Zhang, Y. Wu, X. D. Yu, and N. Mao. 2005. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105: 4120-4126. DOI ScienceOn |
48 | Beyth, S., Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, H. Aslan, E. Galun, and J. Rachmilewitz. 2005. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219. DOI ScienceOn |
49 | Maccario, R., M. Podesta, A. Moretta, A. Cometa, P. Comoli, D. Montagna, L. Daudt, A. Ibatici, G. Piaggio, S. Pozzi, F. Frassoni, and F. Locatelli. 2005. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90: 516-525. |
50 | Mougiakakos, D., R. Jitschin, C. C. Johansson, R. Okita, R. Kiessling, and K. Le Blanc. 2011. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117: 4826-4835. DOI ScienceOn |
51 | Ciccocioppo, R., M. E. Bernardo, A. Sgarella, R. Maccario, M. A. Avanzini, C. Ubezio, A. Minelli, C. Alvisi, A. Vanoli, F. Calliada, P. Dionigi, C. Perotti, F. Locatelli, and G. R. Corazza. 2011. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 60: 788-798. DOI ScienceOn |